Evidence map›Paper›PMID 24476310›Full record

ArticleJournal of experimental & clinical cancer research : CR2014

Inhibition of Aurora B by CCT137690 sensitizes colorectal cells to radiotherapy.

Xiaoyu Wu, Wentao Liu, Qinhong Cao, Che Chen, Zhiwei Chen, Zhe Xu, Weisu Li, Fukun Liu, Xuequan Yao

Abstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Aurora B Inhibitors as Cancer Therapeutics.Molecules (Basel, Switzerland) · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword.Journal of experimental & clinical cancer research : CR · 2016
    Review
  10. The Aurora kinase inhibitors in cancer research and therapy.Journal of cancer research and clinical oncology · 2016
    Review
  11. CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation.International journal of molecular sciences · 2015
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaoyu Wu
Wentao Liu
Qinhong Cao
Che Chen
Zhiwei Chen
Zhe Xu
Weisu Li
Fukun Liu
Xuequan YaoDepartment of Surgical Oncology, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, 155 Guangzhou Road, Nanjing 210029, China. dryxq186@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is the third most commonly diagnosed cancer worldwide. Although surgery remains the best treatment for this disease, adjuvant chemotherapy and radiotherapy are also very important in clinical practice. However, the notorious refractory lack of responses to radiochemotherapy greatly limits the application of radiochemotherapy in the context of colorectal cancer.There is a growing interest in the role that Aurora B may play in colorectal cancer cell survival as well as other cancer subtypes. In the current study, we sought to ascertain whether blocking of Aurora B signaling machinery by a small molecule inhibitor, CCT137690, could synergize radiation-induced colorectal cancer cell death. Results showed that CCT137690 increases the sensitivity of SW620 cells to radiation. Mechanistic studies revealed that Aurora B-Survivin pathway may be involved in this synergistic effect.Taken together, our results for the first time show that Aurora B inhibition and radiation exert a synergistic effect, resulting in enhanced colorectal cancer cell death. This synergistic effect is clinically relevant as lower doses of radiation could be used for cancer treatment, and could provide significant clinical benefits in terms of colorectal cancer management, while reducing unwanted side-effects.

Indexed as

Aurora Kinase BCell Line, TumorCell ProliferationCell SurvivalColorectal NeoplasmsHumansImidazolesInhibitory Concentration 50PyridinesRadiation Tolerance3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo(4,5-b)pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazoleAURKB protein, humanAurora Kinase BImidazolesPyridines

Identifiers

PMID24476310
PMCPMC3976098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.